| Date | Form | Description | Docs | XBRL | Pages |
| 06/27/95 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 06/14/95 | DEF 14A | Definitive proxy statements |
|
15 | |
| 06/09/95 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 |
Latest News & Events
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Read More...